| Revista: | Quimica nova |
| Base de datos: | PERIÓDICA |
| Número de sistema: | 000313330 |
| ISSN: | 0100-4042 |
| Autors: | Melo, Eduardo Borges de1 Bruni, Aline Thaís2 Ferreira, Marcia Miguel Castro3 |
| Institucions: | 1Universidade Estadual do Oeste do Parana, Cascavel, Parana. Brasil 2Universidade Estadual Paulista "Julio de Mesquita Filho", Instituto de Biociencias, Letras e Ciencias Exatas, Sao Jose do Rio Preto, Sao Paulo. Brasil 3Universidade Estadual de Campinas, Instituto de Quimica, Campinas, Sao Paulo. Brasil |
| Any: | 2006 |
| Període: | Jun |
| Volum: | 29 |
| Número: | 3 |
| Paginació: | 555-562 |
| País: | Brasil |
| Idioma: | Portugués |
| Tipo de documento: | Artículo |
| Enfoque: | Aplicado, descriptivo |
| Resumen en inglés | AIDS has the HIV as its etiological agent. Researches has been done to find new pharmacological agents to be used in therapy, because of problems of resistance and side effects. The HIV-integrase inhibitors are some of those new agents that are being studied. This updating focusses on the fundamental information about HIV and HIV-integrase and the main methods being used to develop these new drugs, with examples for each case |
| Disciplines | Química, Medicina |
| Paraules clau: | Farmacología, Inmunología, SIDA, VIH, Integrasa, Inhibidores farmacológicos |
| Keyword: | Chemistry, Medicine, Pharmacology, Immunology, AIDS, HIV, Integrase, Pharmacological inhibitors |
| Text complet: | Texto completo (Ver HTML) |
